ZA97324B - Ischemic myocardium protectant - Google Patents

Ischemic myocardium protectant

Info

Publication number
ZA97324B
ZA97324B ZA97324A ZA97324A ZA97324B ZA 97324 B ZA97324 B ZA 97324B ZA 97324 A ZA97324 A ZA 97324A ZA 97324 A ZA97324 A ZA 97324A ZA 97324 B ZA97324 B ZA 97324B
Authority
ZA
South Africa
Prior art keywords
protectant
ischemic myocardium
myocardium
ischemic
myocardium protectant
Prior art date
Application number
ZA97324A
Inventor
Hisayoshi Fujiwara
Yoshiaki Yoshikuni
Seishi Ochi
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of ZA97324B publication Critical patent/ZA97324B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA97324A 1996-01-17 1997-01-15 Ischemic myocardium protectant ZA97324B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP533196 1996-01-17

Publications (1)

Publication Number Publication Date
ZA97324B true ZA97324B (en) 1998-07-15

Family

ID=11608268

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA97324A ZA97324B (en) 1996-01-17 1997-01-15 Ischemic myocardium protectant

Country Status (3)

Country Link
AU (1) AU1398997A (en)
WO (1) WO1997025987A1 (en)
ZA (1) ZA97324B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108187051A (en) * 2018-01-30 2018-06-22 中国药科大学 Alpha-L-fucosidase and inhibitor are used to prepare the purposes of the drug of prevention treating myocardial ischemia damage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61205455A (en) * 1985-03-11 1986-09-11 Takeda Chem Ind Ltd Low calorie sugar containing composition
JPH0751505B2 (en) * 1987-12-09 1995-06-05 日本新薬株式会社 Cardiovascular agent
CA2088048A1 (en) * 1990-07-26 1992-01-27 Yohji Ezure Process for producing saccharides

Also Published As

Publication number Publication date
WO1997025987A1 (en) 1997-07-24
AU1398997A (en) 1997-08-11

Similar Documents

Publication Publication Date Title
HUP0001650A3 (en) Improved expression vectors
HK1018002A1 (en) Antifungal compositions with improved bioavailability
IL126349A0 (en) Parapoxvirus vectors
IL120785A0 (en) Insulated flask
HU9701949D0 (en) Clamping structure
GB2312265B (en) Structural assembly
HUP9800397A3 (en) Fabric protectant
ZA97324B (en) Ischemic myocardium protectant
GB2325466B (en) Nucleotide sequence from goat liver
GB2311480B (en) Clamping assembly
GB2334257B (en) Rectroviral vectors
GB2331752B (en) Vectors
GB9811543D0 (en) Clamping means
AU7429196A (en) Outrigger fastening means
GB9608125D0 (en) Vectors
GB9608328D0 (en) Improved retroviral vectors
GB2350613B (en) Vectors
ZA974338B (en) Anitfungal compositions with improved bioavailability
GB9624457D0 (en) Retroviral vectors
GB2314372B (en) Clamping assembly
TW295111U (en) Iron structure improvement
GB9617214D0 (en) Vector
GB9725311D0 (en) Vectors
GB9725313D0 (en) Vectors
TW310751U (en) Improved trowel